Please login to the form below

Not currently logged in
Email:
Password:

Pfizer files suit against Merck

Pfizer is to sue Merck over the company's plan to launch a Lipitor-plus-Zetia combination pill in the US

Pfizer is to sue Merck over the company's plan to launch a Lipitor-plus-Zetia combination pill in the US.

According to the Wall Street Journal, Pfizer has filed a patent-infringement lawsuit against Merck, known as MSD outside the US and Canada, to block the drug's introduction for five years.

Cholesterol-lowering drug, Lipitor (atorvastatin), is one of Pfizer's biggest selling medicines and its patent is due to expire in the US by the end of November, 2011.

Merck is aiming to combine a generic version of Lipitor with its Zetia (ezetimibe) product, which also lowers cholesterol but by a different mechanism to Lipitor.

Both Ranbaxy Laboratories and Watson Laboratories are to launch a generic atorvastatin product on November 30, 2011, but Pfizer still holds some patents for Lipitor that do not expire for several years on which it is basing the Merck lawsuit.

13th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics